Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B

FEMS Yeast Research

Volumn 9, Issue 8, 2009, Pages 1302-1311

  Rukayadi, Yaya ^a,b   Lee, Kwanhyoung ^a   Lee, Myoung Su ^a   Yong, Dongeun ^a   Hwang, Jae Kwan ^a  

^a Yonsei University   (South Korea)

^b BOGOR AGRICULTURAL UNIVERSITY   (Indonesia)

Author keywords

Amphotericin B; Anticandidal; Ketoconazole; Synergistic; Xanthorrhizol

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; KETOCONAZOLE; UNCLASSIFIED DRUG; XANTHORRHIZOL;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; FUNGUS GROWTH; GROWTH INHIBITION; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; COLONY COUNT, MICROBIAL; CURCUMA; DRUG SYNERGISM; KETOCONAZOLE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MOLECULAR STRUCTURE; PHENOLS; TIME FACTORS;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CURCUMA XANTHORRHIZA; ISSATCHENKIA ORIENTALIS; PICHIA GUILLIERMONDII;

EID: 70350545469     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2009.00548.x     Document Type: Article

References (34)

1. Alexander BD Perfect JR (1997) Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches. Drug 54 : 657 658.
2. Carson CF, Mee BJ Riley TV (2002) Mechanism of action of Malaleucca alternifolia (tee tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob Agents Ch 46 : 1914 1926.
3. Cavelario C, Pinto E, Goncalves MJ Salgueiro L (2006) Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains. J Appl Microbiol 100 : 1333 1338. (Pubitemid 43725698)
4. Clinical Laboratory Standards Institute (CLSI) (2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
5. Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12 : 564 582.
6. Cuenca-Estrella M (2004) Combination of antifungal agents in therapy - what value are they? J Antimicrob Chemoth 54 : 854 869.
7. Cuenca-Estrella M, Gomez-Lopez A, Garcia-Effron G, Alcazar-Fuoli L, Mellado E, Buitrago MJ Rodriguez-Tudela L (2005) Combined activity in vitro of cospofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus. Antimicrob Agents Ch 49 : 1232 1235.
8. Denning DW, Venkateswarlu K, Oakley KL, Anderson MJ, Manning NJ, Stevens DA, Warnock DW Kelly SL (1997) Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Ch 41 : 1364 1368.
9. Devkatte AN, Zore GB Karuppayil SM (2005) Potential of plant oils as inhibitors of Candida albicans growth. FEMS Yeast Res 5 : 867 873.
10. Dierauf LA Gulland FM (2001) CRN Handbook of Marine Mammal Medicine, 2nd edn. CRN Press, Sausalito, CA.
11. Edwards JE (1991) Invasive Candida infections: evolution of a fungal pathogen. N Engl J Med 324 : 1060 1072.
12. Fonos V Cataldi L (2000) Amphotericin B-induced nephrotoxicity: a review. J Chemother 12 : 463 470.
13. Gallis HA, Drew RH Pickard WW (1990) Amphotericin B: 30 years of clinical experience. Rev Infect Dis 12 : 308 329.
14. Ghannoum MA Rice LB (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbial Rev 12 : 501 517.
15. Graybill JR (1996) The future of antifungal therapy. Clin Infect Dis 22 : S166 S178.
16. Han Y (2007) Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism. Biol Pharm Bull 30 : 1693 1696.
17. Hartsel SC Bolard J (1996) Amphotericin B: new life for an old drug. Trends Pharmachol Sci 12 : 445 449.
18. Hwang JK, Shim JS, Baek NI Pyun YR (2000) Xanthorrhizol: a potential agent from Curcuma xanthorrhiza against Streptococcus mutans. Planta Med 66 : 196 197.
19. Itokawa H, Hirayama F Takeya K (1985) Studies on the antitumor bisabolane sesquiterpenoids isolated from Curcuma xanthorrhiza. Chem Pharm Bull 33 : 3488 3492.
20. Karpanen TJ, Worthington T, Hendry ER, Conway BR Lambert PA (2008) Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of Staphylococcus epidermidis. J Antimicrob Chemoth 62 : 1031 1036.
21. Mayer J, Doubek M, Doubek J, Horký D, Scheer P Stepánek M (2002) Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study. J Infect Dis 186 : 379 388.
22. ®, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies. Diagn Microbiol Infect Dis 51 : 19 29.
23. Pauli A (2006) Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med Res Rev 26 : 223 268.
24. Polak A (2000) The past, present and future of antimycotic combination therapy. Mycoses 42 : 355 370.
25. Rukayadi Y Hwang JK (2007a) The effects of xanthorrhizol on the morphology of Candida cells examined by scanning electron microscopy. Microbiol Indonesia 1 : 98 100.
26. Rukayadi Y Hwang JK (2007b) In vitro antimycotic activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. against opportunistic filamentous fungi. Phytother Res 21 : 434 438.
27. Rukayadi Y Hwang JK (2007c) In vitro anti-Malassezia activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. Lett Appl Microbiol 44 : 126 130.
28. Rukayadi Y, Yong D Hwang JK (2006) In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. J Antimicrob Chemoth 57 : 1231 1234.
29. Shin S Lim S (2004) Antifungal effects of herbal essential oils alone and in combination with ketoconazole against Trichophyton spp. J Appl Microbiol 97 : 1289 1296.
30. Shin S Pyun M (2004) Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B. Phytother Res 18 : 827 830.
31. Tim Cushnie TP Lamb AJ (2005) Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26 : 343 356.
32. Vartivarian SE, Anaissie EJ Bodey GP (1993) Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin Infect Dis 17 : S487 S491.
33. Zhang L, Yan K, Zhang Y et al 2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. P Natl Acad Sci USA 104 : 4606 4611.
34. Zhu LP, Gil-Lamaignere C Muller FMC (2004) Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China. Mycoses 47 : 319 325.